Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Jpn J Clin Oncol. 2010 Nov;40(11):1087-91. doi: 10.1093/jjco/hyq096. Epub 2010 Jun 24.
To verify the indication of diagnostic ureteropyeloscopy based on clinical features for upper urinary tract urothelial cancer with over 100 patients and over a 10-year series.
From January 1997 to December 2008, consecutive 129 units in 124 patients underwent ureteropyeloscopy to obtain a definitive diagnosis of upper urinary tract cancer or to rule out a malignancy. Patients were divided into four subgroups based on voided urine cytology and preoperative radiographic findings: group A (n = 8), positive urine cytology and positive radiographic findings; group B (n = 4), positive cytology and negative radiographic findings; group C (n = 55), negative cytology and positive radiographic findings and group D (n = 62), gross hematuria originating from the upper urinary tract with negative cytology and negative radiographic findings. Ureteropyeloscopic findings were compared with radiographic and cytological results. Adverse effects were also investigated.
In group A, all patients had confirmed cancer. In group B, one revealed small cancer and the remaining three confirmed carcinoma in situ by biopsy with ureteropyeloscopy. In groups C and D, 33 patients (60%) and four (6.5%) revealed cancer. Seventy-eight patients out of 80 (97.5%) in groups C and D were confirmed to have benign disease. No patient was found with malignancy during follow up after negative finding of ureteropyeloscopy.
Ureteropyeloscopy can help in detecting upper urinary tract cancer or to rule out malignancy for patients with negative voiding cytology. However, ureteropyeloscopy is redundant for patients with positive radiographic findings and positive voiding cytology.
通过对 100 多例、10 年以上连续病例的临床特征进行分析,验证基于诊断性输尿管肾盂镜检查对上尿路尿路上皮癌的适应证。
1997 年 1 月至 2008 年 12 月,124 例患者的 129 个单位连续进行了输尿管肾盂镜检查,以明确上尿路癌症的诊断或排除恶性肿瘤。根据尿细胞学和术前影像学检查结果,患者分为 4 个亚组:A 组(n = 8),细胞学阳性和影像学阳性;B 组(n = 4),细胞学阳性和影像学阴性;C 组(n = 55),细胞学阴性和影像学阳性;D 组(n = 62),来源于上尿路的肉眼血尿,细胞学和影像学均为阴性。比较输尿管肾盂镜检查结果与影像学和细胞学结果。还调查了不良反应。
在 A 组中,所有患者均确诊为癌症。在 B 组中,1 例发现小癌,其余 3 例通过活检联合输尿管肾盂镜检查确诊为原位癌。在 C 组和 D 组中,33 例(60%)和 4 例(6.5%)患者发现癌症。C 组和 D 组的 78 例患者(97.5%)被证实患有良性疾病。在输尿管肾盂镜检查阴性随访期间,未发现任何患者患有恶性肿瘤。
对于细胞学阴性的患者,输尿管肾盂镜检查有助于检测上尿路癌或排除恶性肿瘤。然而,对于影像学和细胞学检查均阳性的患者,输尿管肾盂镜检查是多余的。